Phase II Study of Vismodegib in Patients With SMO- or PTCH1-Mutated Tumors: Results From the National Cancer Institute Molecular Analysis for Therapy Choice Eastern Cooperative Oncology Group-American ...
Overview: Practical projects show how data supports real decisions across industries and services.Analytics skills grow ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback